What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Immune system
- Gene
The scientist’s investigation covers issues in Immunology, Sepsis, Septic shock, Immune system and Intensive care.
The study incorporates disciplines such as Calcitonin and Prospective cohort study in addition to Immunology.
His studies in Sepsis integrate themes in fields like Clinical trial, Immunity and Intensive care medicine.
Guillaume Monneret focuses mostly in the field of Immune system, narrowing it down to matters related to Inflammation and, in some cases, Immunotherapy, Cellular Immunology, Innate immune system, Macrophage and Effector.
His studies deal with areas such as Human leukocyte antigen, IL-2 receptor and Shock as well as Intensive care.
His Immunosuppression research integrates issues from Infectious disease and Monocyte.
His most cited work include:
- Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy (1093 citations)
- Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach (807 citations)
- Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock (334 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Immunology, Sepsis, Septic shock, Internal medicine and Immune system.
Immunology is a component of his Immunosuppression, Monocyte, IL-2 receptor, Lymphocyte and Cytokine studies.
MEDLINE is closely connected to Intensive care medicine in his research, which is encompassed under the umbrella topic of Sepsis.
His Septic shock study incorporates themes from Whole blood, Shock, Intensive care, Biomarker and Intensive care unit.
The concepts of his Intensive care study are interwoven with issues in Resuscitation, Human leukocyte antigen and Confidence interval.
His research in the fields of Procalcitonin and Prospective cohort study overlaps with other disciplines such as In patient.
He most often published in these fields:
- Immunology (50.35%)
- Sepsis (36.36%)
- Septic shock (32.87%)
What were the highlights of his more recent work (between 2017-2020)?
- Sepsis (36.36%)
- Immunology (50.35%)
- Septic shock (32.87%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Sepsis, Immunology, Septic shock, Internal medicine and Antigen.
His work often combines Sepsis and 2019-20 coronavirus outbreak studies.
Many of his studies on Immunology involve topics that are commonly interrelated, such as Receptor.
Guillaume Monneret has included themes like Transcriptome, Immune system, Microarray, Biomarker and Bone marrow in his Septic shock study.
In general Internal medicine study, his work on Whole blood, Risk of mortality and Systemic inflammatory response syndrome often relates to the realm of In patient, thereby connecting several areas of interest.
His Immunosuppression research incorporates themes from Icu admission and Incidence.
Between 2017 and 2020, his most popular works were:
- Immunotherapies for COVID-19: lessons learned from sepsis. (49 citations)
- A standardized flow cytometry procedure for the monitoring of regulatory T cells in clinical trials. (22 citations)
- LTR-retrotransposon transcriptome modulation in response to endotoxin-induced stress in PBMCs (16 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Immune system
- Gene
Guillaume Monneret mostly deals with Coronavirus disease 2019, Sepsis, Flow cytometry, Immunology and Staining.
His work carried out in the field of Coronavirus disease 2019 brings together such families of science as Critically ill and Pneumonia.
The various areas that Guillaume Monneret examines in his Flow cytometry study include Whole blood, Clinical trial, Red blood cell, Interleukin-7 receptor and FOXP3.
His CD40 research extends to Immunology, which is thematically connected.
His Staining research is multidisciplinary, incorporating elements of Blood volume and Cytometry.
His Pandemic study combines topics in areas such as Compassionate Use Trials, Compassionate Use, Intensive care medicine, Interleukin and Immune monitoring.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
